Skip to main content

Day: September 17, 2020

Tattooed Chef Reports Second Quarter 2020 Financial Results

Record First Half Net Sales of $67.9 MillionExpect to Achieve Adjusted EBITDA Target of $17 Million for Fiscal 2020PARAMOUNT, Calif. and DELRAY BEACH, Fla., Sept. 17, 2020 (GLOBE NEWSWIRE) — Ittella International – The Tattooed Chef brand, a plant-based food company with a broad portfolio of innovative products (“Tattooed Chef” or the “Company”), today announced financial results for the three and six months ended June 30, 2020. As previously announced, Tattooed Chef and Forum Merger II Corporation (Nasdaq: FMCI) (“Forum”), a special purpose acquisition company, have entered into a definitive agreement (the “Business Combination Agreement”) for a business combination that will introduce Tattooed Chef as a Nasdaq-listed public company.Sam Galletti, President and CEO of Tattooed Chef said, “We are pleased with our record financial...

Continue reading

B2Digital Signs Agreement to Acquire Two Premier Fitness Facilities to Expand Official B2 Training Facilities Network

Tampa, FL, Sept. 17, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — B2Digital Incorporated (the “Company” or “B2Digital”) (OTCMKTS:BTDG), the premier development league for mixed martial arts (“MMA”), is excited to announce that the Company has signed an agreement to acquire two additional premier fitness facilities in Merrillville and Valparaiso, Indiana. “We are looking forward to expanding our B2 Training Facilities Network to these two new locations,” noted Greg P. Bell, Chairman & CEO of B2Digital. “They will allow us to capitalize on our existing relationships with the local MMA gyms and effectively double our paying customer base overnight for our ONE More Gym business. These two new fitness facilities fit perfectly within our strategic roadmap to continue expanding our capability to develop future MMA stars. We plan...

Continue reading

Auris Medical Provides Business Update and Reports First Half 2020 Financial Results

Advancing Phase 2 trial with AM-125 in acute vertigo based on positive interim dataPositive outcome from AM-201 trial in prevention of antipsychotic-induced weight gainAddition of new intranasal program with development of drug-free spray for protection against airborne pathogens and allergensReview of strategic options initiatedHamilton, Bermuda, September 17, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today provided a business update and announced financial results for the first half of the 2020 financial year ended June 30, 2020.“Over the past few months we reached major milestones with our intranasal betahistine program, reporting positive safety and tolerability data...

Continue reading

Vaccinex Announces Clinical Collaboration with Merck to Evaluate Pepinemab in Combination with KEYTRUDA® in Advanced, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

ROCHESTER, N.Y., Sept. 17, 2020 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a novel approach to treating cancer and neurodegenerative disease through the inhibition of SEMA4D, today announced that it has entered into a clinical collaboration agreement with Merck (known as MSD outside the US and Canada), through a subsidiary, to evaluate the combination of Vaccinex’s investigational SEMA4D inhibitor, pepinemab, and Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), in the treatment of patients with advanced, recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).“We are pleased to be working with Merck to evaluate the potential of pepinemab in combination with KEYTRUDA® to further improve the efficacy of cancer immunotherapy,” said Maurice Zauderer, Ph.D.,...

Continue reading

AgraFlora’s Subsidiary Farmako Obtains Additional EU-GMP Cannabis for Distribution in Germany

VANCOUVER, British Columbia, Sept. 17, 2020 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc.  (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) is pleased to announce that on September 9, 2020, its wholly owned subsidiary Farmako GmbH (“Farmako”) has entered into a binding distribution agreement (the “Distribution Agreement”) with Adjupharm GmbH (“Adjupharm”), the German subsidiary of IM Cannabis Corp. (“IMC”) (CSE:IMCC).Under the Distribution Agreement, Adjupharm will supply EU-GMP medical cannabis flower to Farmako for distribution to medical cannabis patients in Germany over a 3 year term. Farmako will distribute the products in Germany under the IMC brand to its established network of German pharmacies. The Distribution Agreement is expected to launch with first products in October 2020.The...

Continue reading

Cue Biopharma Welcomes Tamar Howson to its Board of Directors

Appointment augments board capabilities with a seasoned business development executive as Cue Biopharma executes its next stage of corporate developmentCAMBRIDGE, Mass., Sept. 17, 2020 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body, announced today the appointment of Tamar Howson to its board of directors. Ms. Howson brings broad corporate and business development experience to the board, having held executive leadership positions in several global biopharmaceutical and pharmaceutical companies, as well as her many board appointments.“We are very pleased to welcome Tamar Howson to the Cue Biopharma board of directors,” said Frank Morich, M.D., Ph.D., chairman of the...

Continue reading

Commerce Signals Launches Merchant Tracker—First Market Intelligence Solution to Monitor County-Level Consumer Spending By Merchant

Jersey City, NJ, Sept. 17, 2020 (GLOBE NEWSWIRE) — Commerce Signals, a Verisk Financial business and leading source of U.S. consumer spending insights, today announced the availability of the Commerce Signals Merchant Tracker, a ground-breaking solution for businesses to better understand where consumers are spending and how their own sales compare to other merchants. Never before have businesses been able to benchmark sales and market share vs. other named merchants at a county level. Spending trends are also broken-out between online and in-store sales.The Commerce Signals Merchant Tracker allows retailers to access weekly views of purchases, returns, average ticket, and market share—all from an easy-to-use and intuitive online dashboard. A datacube is also available for custom analysis. This new solution is a powerful tool for...

Continue reading

SurveyMonkey’s Latest App for Microsoft Teams Helps Organizations Mobilize for a Future of Work in Which 71% of Workers Want to Continue Working from Home

SAN MATEO, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) — SurveyMonkey (Nasdaq: SVMK), a leader in agile software solutions for customer experience, market research, and survey feedback, today announced its latest release for Microsoft Teams as companies across the globe mobilize to make a remote workforce more productive, inclusive, and engaged. The latest release helps organizations use in-the-moment feedback to improve employee experience, underscoring the importance of agility in collecting and acting on feedback for organizations looking to optimize a work landscape forever changed by the global pandemic.In a recent study, SurveyMonkey and Microsoft found that 28% of people say that their engagement level at work has declined, and 25% report a hit to their productivity. In addition, 71% of respondents report a desire to continue...

Continue reading

Avadel to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

DUBLIN, Ireland, Sept. 17, 2020 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL) a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate, today announced that its executive team will be presenting at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit taking place September 21 – 23, 2020.In addition, management will be participating in one-on-one meetings with investors who are registered to attend the conference.About Avadel Pharmaceuticals plc:Avadel Pharmaceuticals plc (Nasdaq: AVDL) is an emerging biopharmaceutical company. The Company’s primary focus is the development and FDA approval of FT218, an investigational, once-nightly formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in patients with narcolepsy. For more...

Continue reading

National MI Integrates with Lender Price

EMERYVILLE, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) — National Mortgage Insurance Corporation (National MI), a subsidiary of NMI Holdings, Inc. (NASDAQ: NMIH), announced that it is fully integrated with Lender Price, a leading cloud-based product, pricing and eligibility (PPE) engine provider for the mortgage finance industry. Loan officers now have instant access to National MI’s risk-based Rate GPS® through the Lender Price PPE platform.  “National MI is excited to team with Lender Price,” said Norm Fitzgerald, National MI’s chief sales officer. “This integration reinforces our commitment to streamlining and automating the process of ordering private mortgage insurance while mitigating the chance for errors. It also reduces the time from application to closing for loan originators and consumers.”“We are very pleased to partner...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.